Johnson & Johnson (JNJ)

144.00
0.32 0.22
NYSE
Prev Close 143.68
Open 144.50
Day Low/High 143.22 / 144.66
52 Wk Low/High 109.16 / 157.00
Volume 3.06M
Exchange NYSE
Shares Outstanding 2632.54B
Market Cap 378.24B
P/E Ratio 25.25
Div & Yield N.A. (N.A)
U.S. Dollar on the Edge: What Does it Mean for Investors?

U.S. Dollar on the Edge: What Does it Mean for Investors?

A weak dollar could provide a substantial tailwind for these companies.

Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting

Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting

The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.

It's Finally Time for Energy Stocks

It's Finally Time for Energy Stocks

One of the most-hated sectors of the market is taking off, and it's not too late to get on board.

Jim Cramer: This Is All Playing Out Like a Stephen King Novel

Jim Cramer: This Is All Playing Out Like a Stephen King Novel

What happens when everyone hunkers down, creating their own de facto stay-in-place lockdown?

Take Advantage of Overblown Healthcare Worries With This Trade

Take Advantage of Overblown Healthcare Worries With This Trade

Monday's action in Johnson & Johnson is a fadeable event.

The Market's Week That Was, Upcoming Elections, the Economy, Stimulus

The Market's Week That Was, Upcoming Elections, the Economy, Stimulus

Portfolio managers are starting to see a very strong 2021 for markets and the economy regardless of electoral results.

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

The Market Needs Some Rest but There Are Many Positives at Work

The Market Needs Some Rest but There Are Many Positives at Work

Market participants ignore negative news and continue to pursue individual stocks into earnings season.

We Fell, but It Could Have Been Worse

We Fell, but It Could Have Been Worse

Given the news of the day, you'd think we would have had a violent pullback -- instead here's what we got.

Jim Cramer: Let the Market's Patterns Guide You

Jim Cramer: Let the Market's Patterns Guide You

Some patterns reveal themselves easily, and you can spot them ahead of the computer programs. Here are examples of them, and how to act.

Jim Cramer: Here's How We're Going to Beat Covid-19

Jim Cramer: Here's How We're Going to Beat Covid-19

Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

Now, that we have confirmation from the Nasdaq Composite, I think we can say equity markets are indeed back in what I would consider an uptrend.

Big-Cap Technology Regains Its Leadership as Banks Kick Off Earnings Season

Big-Cap Technology Regains Its Leadership as Banks Kick Off Earnings Season

There was some significant rotational action Monday and we'll see if that continues as we move into earnings reports.

Jim Cramer: Here's Why the President Is Gambling With Stimulus

Jim Cramer: Here's Why the President Is Gambling With Stimulus

The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

I see no reason to flee this name, therefore, I am not.

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

The result has been a technical breakdown in risk-asset pricing -- and the main culprit is without a doubt, the inability of Congress to compromise.

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.

Jim Cramer: We're Feeling the Wrath of the Sellers - And It's About Time

Jim Cramer: We're Feeling the Wrath of the Sellers - And It's About Time

The greedy are, at last, getting blown out, and the prudent being vindicated. I see three buckets of stocks that intrigue me now.

Auction Action

The 10-year U.S. note auction was soft. The yield of 0.704% was above the when issued of about 0.695%. The bid to cover of 2.30 was below the 12 month average of 2.47. Also, dealers were left with 27% of the auction vs. the one year average of 25%. ...

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.

The Week Ahead, Markets Haven't Been Wrong, Closer to a Vaccine? Watching J&J

The Week Ahead, Markets Haven't Been Wrong, Closer to a Vaccine? Watching J&J

The equity market recovery is just as sloppy in performance as the economy itself.

The Nasdaq and Great Stock Picking Continue to Lead the Market Higher

The Nasdaq and Great Stock Picking Continue to Lead the Market Higher

If you're looking for some corrective action to gain momentum, then you will have to wait for broader selling.

Iconic Johnson & Johnson Is Poised for an Upside Breakout

Iconic Johnson & Johnson Is Poised for an Upside Breakout

Here's how we would trade the blue chip stock.

Emergent BioSolutions Could See Further Upside Gains

Emergent BioSolutions Could See Further Upside Gains

Most of the indicators are still bullish in this name, although some profit-taking may be occurring.

Jim Cramer: Betting Against Science Is a Mug's Game

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.